The epidemiology of hypertension in India has undergone a malignant shift, moving from a disease of the elderly to a ...

Background Multiple long-term conditions (MLTCs) are common among individuals with heart failure (HF); however, the influence ...

As December draws to a close and Christmas arrives, investors are pausing to look back and assess a year that never followed ...

The incidence and prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing, along with the aging population and the ongoing rise in risk factors such as hypertension, ...

Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with ...

Lexeo Therapeutics, Inc. has surged after FDA alignment on a pivotal trial for LX2006, targeting Friedreich’s ataxia cardiomyopathy. LX2006 shows promising efficacy and safety, with significant LVMI ...

As the ACC Middle East 2025 Together With 16th Emirates Cardiac Society Conference winds down in Dubai, UAE, the three winners of the conference's abstract competition were announced and invited to ...

Jon Stewart‘s episode of The Daily Show tonight excoriated the new national “pastime” of the “left-right blame game” following mass shootings. Before delving into his main topic of the night, the ...

Mavacamten is approved to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). However, its effects in nonobstructive HCM remain uncertain. We conducted a phase 3, ...

Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...

LBBB is linked to electrical abnormalities, causing inefficient heart pumping, dilation, and systolic dysfunction. The study found LBBB associated with increased heart failure risk, surpassing other ...